The combination of sucrose dilaurate and sucrose laurate suppresses HMGB1: an enhancer of melanocyte dendricity and melanosome transfer to keratinocytes
- PMID: 35014730
- DOI: 10.1111/jdv.17846
The combination of sucrose dilaurate and sucrose laurate suppresses HMGB1: an enhancer of melanocyte dendricity and melanosome transfer to keratinocytes
Abstract
Background: Hyperpigmented spots are common issues in all ethnicities, involving multiple intrinsic and extrinsic factors such as UVB exposure, hormone balance, inflammatory status and ageing.
Objectives: To determine (i) melanocyte dendricity in multiple facial spot types, (ii) impact of High Mobility Group Box 1 (HMGB1), and the combination of sucrose dilaurate and sucrose laurate (SDL) on melanogenesis and melanocyte dendricity, and (iii) SDL effect on facial spots in a human use test.
Methods: Facial spot and adjacent non-spot skin biopsies were collected from Chinese women (age 20-70). Histological assessment of melanocyte dendricity was performed for 3 spot types (solar lentigo, melasma and postinflammatory hyperpigmentation) by immunofluorescent staining for c-kit/MITF. Keratinocyte, melanocyte and melanocyte-keratinocyte co-culture models were used to assess HMGB1 release by UVB radiation, the effects of HMGB1 and SDL on melanin production, melanocyte dendricity and melanosome transfer. The effect of an SDL-containing moisturizer on appearance of facial hyperpigmented spots was assessed against a vehicle control in an 8-week human use test.
Results: Melanocytes in spot areas are more dendritic than melanocytes in adjacent non-spot skin across three investigated spot types. In cell culture models, a moderate UVB-radiation exposure caused release of HMGB1 from keratinocytes. HMGB1 did not alter melanin production in melanocytes, but enhanced melanocyte dendricity and melanosome transfer. SDL reduced HMGB1 release from keratinocytes, inhibited melanin production, reversibly suppressed melanocyte dendricity and reduced melanosome transfer. In the human use test, SDL-containing moisturizer reduced appearance of spots versus vehicle.
Conclusion: Increased melanocyte dendricity was observed in multiple types of facial spots. Addition of HMGB1 protein increased melanocyte dendricity and melanosome transfer in cell cultures, implicating potential involvement in spot formation. SDL suppressed melanin production, melanocyte dendricity and melanosome transfer in vitro and reduced appearance of spots in the use test, suggesting SDL is an effective solution to address hyperpigmented spot concerns.
© 2022 European Academy of Dermatology and Venereology.
Similar articles
-
Role of interleukin-6 and endothelin-1 receptors in enhanced melanocyte dendricity of facial spots and suppression of their ligands by niacinamide and tranexamic acid.J Eur Acad Dermatol Venereol. 2024 Jan;38 Suppl 2:3-10. doi: 10.1111/jdv.19719. J Eur Acad Dermatol Venereol. 2024. PMID: 38116639
-
Effective inhibition of melanosome transfer to keratinocytes by lectins and niacinamide is reversible.Exp Dermatol. 2005 Jul;14(7):498-508. doi: 10.1111/j.0906-6705.2005.00309.x. Exp Dermatol. 2005. PMID: 15946237 Clinical Trial.
-
The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer.Br J Dermatol. 2002 Jul;147(1):20-31. doi: 10.1046/j.1365-2133.2002.04834.x. Br J Dermatol. 2002. PMID: 12100180 Clinical Trial.
-
Keratinocyte-melanocyte interactions during melanosome transfer.Pigment Cell Res. 2001 Aug;14(4):236-42. doi: 10.1034/j.1600-0749.2001.140402.x. Pigment Cell Res. 2001. PMID: 11549105 Review.
-
Recent development of signaling pathways inhibitors of melanogenesis.Cell Signal. 2017 Dec;40:99-115. doi: 10.1016/j.cellsig.2017.09.004. Epub 2017 Sep 12. Cell Signal. 2017. PMID: 28911859 Review.
Cited by
-
Current Understanding of the Role of Senescent Melanocytes in Skin Ageing.Biomedicines. 2022 Dec 2;10(12):3111. doi: 10.3390/biomedicines10123111. Biomedicines. 2022. PMID: 36551868 Free PMC article. Review.
-
Dynamic Network Driver Analysis Identifies Master Factors Associated with Progression of Solar Lentigines.Biology (Basel). 2025 Jul 17;14(7):876. doi: 10.3390/biology14070876. Biology (Basel). 2025. PMID: 40723431 Free PMC article.
-
Peptide Design for Enhanced Anti-Melanogenesis: Optimizing Molecular Weight, Polarity, and Cyclization.Drug Des Devel Ther. 2025 Jan 27;19:645-670. doi: 10.2147/DDDT.S500004. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 39896936 Free PMC article. Review.
References
-
- Vashi NA, Kundu RV. Facial hyperpigmentation: causes and treatment. Br J Dermatol 2013; 169: 41-56.
-
- Bastonini E, Kovacs D, Picardo M. Skin pigmentation and pigmentary disorders: focus on epidermal/dermal cross-talk. Ann Dermatol 2016; 28: 279-289.
-
- Duval C, Régnier M, Schmidt R. Distinct melanogenic response of human melanocytes in mono-culture, in co-culture with keratinocytes and in reconstructed epidermis, to UV exposure. Pigment Cell Res 2001; 14: 348-355.
-
- Bianchi ME, Crippa MP, Manfredi AA et al. High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair. Immunol Rev 2017; 280: 74-82.
-
- Scott GA, Jacobs SE, Pentland AP. sPLA2-X stimulates cutaneous melanocyte dendricity and pigmentation through a lysophosphatidylcholine-dependent mechanism. J Invest Dermatol 2006; 126: 855-861.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources